| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President As and Aet | VP Gm Advanced Surgery
1 company
Stanley W Peters III last filed a Form 4 in June 2024, as President As and Aet at CNMD.
Our model assigns Stanley W Peters III a strong insider score of 79/100, based on 10 past trades. Over a 12-month horizon, 90.0% of those trades were profitable, with an average 12-month return of +30.5%.
At the last filing, the largest reported position was 63 shares of CNMD. The CNMD filings lean toward selling, a net 69,898 shares.
Stanley W Peters III has 43 Form 4 filings on record from February 2015 to June 2024, all as President As and Aet at Conmed (CNMD), 2015–2024.
The 79 reported transactions were 23 option exercises, 21 open-market sales, 15 stock awards and 12 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 18 sales worth about $8.3M.
The largest open-market sale was 14,000 shares of CNMD at an average $154.06 on November 4, 2021, about $2.2M. Twelve months later CNMD was down 51%.
None of the 7 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
Shares as reported in the last Form 4 for each company; the most recent is from June 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14, 2024 | CNMD Conmed Corp | President As and Aet | Sale+OE | 4,000 | $71.82 | $287,280.00 | -98.4% | +8.2% | -24.7% | |
| Dec 4, 2023 | CNMD Conmed Corp | President As and Aet | Sale+OE | 2,300 | $109.93 | $252,833.48 | -97.3% | -25.7% | -32.8% | |
| Nov 7, 2023 | CNMD Conmed Corp | President As and Aet | Sale+OE | 1,200 | $102.40 | $122,874.00 | -95.0% | -18.0% | -24.8% | |
| Sep 13, 2023 | CNMD Conmed Corp | President As and Aet | Sale+OE | 2,000 | $107.31 | $214,629.20 | -96.9% | +1.2% | -28.4% | |
| Jun 8, 2023 | CNMD Conmed Corp | VP Gm Advanced Surgery | Sale+OE | 5,000 | $131.14 | $655,676.00 | -98.8% | -17.3% | -42.0% | |
| May 22, 2023 | CNMD Conmed Corp | VP Gm Advanced Surgery | Sale+OE | 1,500 | $120.90 | $181,342.50 | -96.0% | -11.9% | -37.9% | |
| May 18, 2023 | CNMD Conmed Corp | VP Gm Advanced Surgery | Sale+OE | 1,500 | $119.24 | $178,861.05 | -96.0% | -7.5% | -37.2% | |
| Aug 12, 2022 | CNMD Conmed Corp | VP Gm Advanced Surgery | Sale+OE | 7,500 | $100.90 | $756,750.00 | -99.2% | -21.2% | +9.9% | |
| Feb 25, 2022 | CNMD Conmed Corp | VP Gm Advanced Surgery | Sale+OE | 10,700 | $148.41 | $1,588,036.42 | -99.4% | -21.9% | -36.2% | |
| Nov 4, 2021 | CNMD Conmed Corp | VP Gm Advanced Surgery | Sale+OE | 14,000 | $154.06 | $2,156,854.00 | -99.6% | -9.9% | -50.5% |